Publications by authors named "Szu-Ching Yin"
Article Synopsis
- This study explored the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and its impact on mortality related to cardiometabolic risks, involving over 343,000 adults aged 30 and older.
- The findings revealed that 36.4% of participants had MASLD, with a notable association between abnormal liver enzymes and higher cardiometabolic comorbidities among these individuals.
- Patients with MASLD faced a significantly increased risk of dying from all causes, as well as from cardiovascular and diabetes-related issues, emphasizing the need for monitoring and lifestyle guidance for those affected.
Introduction: The prospective study aimed to investigate the long-term associated risks of cirrhosis and hepatocellular carcinoma (HCC) across various subtypes of steatotic liver disease (SLD).
Methods: We enrolled 332,175 adults who participated in a health screening program between 1997 and 2013. Participants were categorized into various subtypes, including metabolic dysfunction-associated SLD (MASLD), MASLD with excessive alcohol consumption (MetALD), and alcohol-related liver disease (ALD), based on ultrasonography findings, alcohol consumption patterns, and cardiometabolic risk factors.
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.
Clin Gastroenterol Hepatol
June 2024
Article Synopsis
- - The study investigates the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and the risk of developing cirrhosis and hepatocellular carcinoma (HCC) in people with chronic hepatitis B (CHB) or C infections.
- - Out of 336,866 adults studied, 36.4% had MASLD, which significantly increased the risk of cirrhosis and HCC, especially in those with underlying CHB or C infections.
- - The results emphasize the importance of addressing chronic viral hepatitis treatment prior to managing MASLD due to the heightened risks associated with both conditions.